These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8227324)

  • 21. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
    Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
    Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New perspectives on pancreatic islet glucokinase.
    Meglasson MD; Matschinsky FM
    Am J Physiol; 1984 Jan; 246(1 Pt 1):E1-13. PubMed ID: 6364828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type.
    Ralph EC; Sun S
    Biochemistry; 2009 Mar; 48(11):2514-21. PubMed ID: 19187021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic islet mitochondrial glycerophosphate dehydrogenase deficiency in two animal models of non-insulin-dependent diabetes mellitus.
    Fabregat ME; Novials A; Giroix MH; Sener A; Gomis R; Malaisse WJ
    Biochem Biophys Res Commun; 1996 Mar; 220(3):1020-3. PubMed ID: 8607784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-cell secretory defect caused by mutations in glucokinase gene.
    Page R; Hattersley A; Turner R
    Lancet; 1992 Nov; 340(8828):1162-3. PubMed ID: 1359234
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.
    Miller SP; Anand GR; Karschnia EJ; Bell GI; LaPorte DC; Lange AJ
    Diabetes; 1999 Aug; 48(8):1645-51. PubMed ID: 10426385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of D-glucose anomers in pancreatic islets (review).
    Malaisse WJ
    Int J Mol Med; 2003 Dec; 12(6):911-6. PubMed ID: 14612965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.
    Postic C; Shiota M; Niswender KD; Jetton TL; Chen Y; Moates JM; Shelton KD; Lindner J; Cherrington AD; Magnuson MA
    J Biol Chem; 1999 Jan; 274(1):305-15. PubMed ID: 9867845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiology and pathology of islet metabolism.
    Malaisse WJ
    Diabete Metab; 1994; 20(2):95-8. PubMed ID: 7805957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-specific roles of glucokinase in glucose homeostasis.
    Postic C; Shiota M; Magnuson MA
    Recent Prog Horm Res; 2001; 56():195-217. PubMed ID: 11237213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucokinase].
    Eto K; Kadowaki T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():523-34. PubMed ID: 12238093
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucokinase and glucose transporter expression in liver and islets: implications for control of glucose homoeostasis.
    Newgard CB; Quaade C; Hughes SD; Milburn JL
    Biochem Soc Trans; 1990 Oct; 18(5):851-3. PubMed ID: 2083694
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics.
    Matschinsky FM
    Diabetes; 2002 Dec; 51 Suppl 3():S394-404. PubMed ID: 12475782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.
    Gidh-Jain M; Takeda J; Xu LZ; Lange AJ; Vionnet N; Stoffel M; Froguel P; Velho G; Sun F; Cohen D
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1932-6. PubMed ID: 8446612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucokinase, glucose sensing, and diabetes.
    Mueckler M
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):784-5. PubMed ID: 8430085
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of pancreatic beta-cells in type I and II diabetes: clinical implications?].
    Waeber G
    Rev Med Suisse Romande; 1995 Sep; 115(9):627-34. PubMed ID: 7481346
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucokinase and non-insulin-dependent diabetes.
    O'Rahilly S
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):17-9. PubMed ID: 8348703
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes.
    Matschinsky FM
    Diabetes; 1990 Jun; 39(6):647-52. PubMed ID: 2189759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucokinase gene mutation and impaired glucose uptake by liver.
    Sakura H; Kawamori R; Kubota M; Morishima T; Kamada T; Akanuma Y; Yazaki Y; Kadowaki T
    Lancet; 1993 Jun; 341(8859):1532-3. PubMed ID: 8099400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.